Chen Qin, M.S.

Department:Clinical Laboratory Medicine

Medical School:Wenzhou Medical University, China

Academic Rank:Associate Chief Techinician


Clinical / Research Interests

Clinical hematology and immunology; immunology of blood-borne viral infections and thyroid disease.

Professional Highlights

Professional Appointments

Member, Medical Laboratory Branch, Zhejiang Medical Association

Member, Immunology Branch, Zhejiang Immunology Association

Member, Metabolic Diseases, Clinical Laboratory Branch, Chinese Association of Integrative Medicine

Education Experience

Research Summary

Publications

Chen Q, Yu WY, Zhang HH, Zhang SZ, Fang J, Wu F, Ying HZ, Yu CH. PBX3 Promotes Tumor Growth and Angiogenesis via Activation of AT1R/VEGFR2 Pathway in Papillary Thyroid Carcinoma. Biomed Res Int. 2020: 8954513.

Hu HY, Yu CH, Zhang HH, Zhang SZ, Yu WY, Yang Y, Chen Q. Exosomal miR-1229 derived from colorectal cancer cells promotes angiogenesis by targeting HIPK2. Int J Biol Macromol. 2019, 132: 470-477.

Ying HZ, Zhang HH, Yu WY, Li L, Wu F, Chen Q, Yang Y, Yu CH. Protective effects of diketopiperazines from Moslae Herba against influenza A virus-induced pulmonary inflammation via inhibition of viral replication and platelets aggregation. J Ethnopharmacol. 2018, 215:156-166.

Ying HZ, Chen Q, Zhang WY, Zhang HH, Ma Y, Zhang SZ, Fang J, Yu CH.  PDGF signaling pathway in hepatic fibrosis pathogenesis and therapeutics (Review). Mol Med Rep. 2017, 16 (6):7879-7889.

Xie Hui, Zhang Huanhuan, Ying Huazhong, Yu Chenhuan, Zhang Songzhao, Chen Qin. Expression of microRNA-22 in thyroid papillary carcinoma and its relationship with chemotherapy sensitivity. International Journal of Epidemiology and Infectious Disease.2017, 44(2):95-99.


Current Program

MiR-22 promotes self-renewal, invasion and metastasis of thyroid papillary stem cells. Funding Source: Natural Science Foundation of Zhejiang (LQ16H200003).

Find People

Search by Family Name

Find A Department

Search by Departments